Detalhe da pesquisa
1.
The deficiency of DNASE1L3 does not affect systemic sclerosis pathogenesis in two inducible murine models of the disease.
Eur J Immunol
; : e2350903, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38576111
2.
Evolution of monoclonal gammopathy of undetermined significance in patients treated with JAK inhibitors for rheumatic diseases: data from the MAJIK-SFR registry.
Rheumatology (Oxford)
; 63(3): 787-790, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37540112
3.
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis.
Rheumatology (Oxford)
; 2024 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460548
4.
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response.
Immunity
; 42(6): 1159-70, 2015 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26070486
5.
Pathogenic variants in the NLRP3 LRR domain at position 861 are responsible for a boost-dependent atypical CAPS phenotype.
J Allergy Clin Immunol
; 152(5): 1303-1311.e1, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37506976
6.
Mouth opening in systemic sclerosis: A longitudinal analysis from the French National Cohort Study.
J Intern Med
; 2023 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37376708
7.
Occupational quantitative exposure to crystalline silica, solvents, pesticides, and risk of clinical forms of systemic sclerosis.
Rheumatology (Oxford)
; 2023 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37963059
8.
The response to TNF blockers depending on their comparator in rheumatoid arthritis clinical trials: the lessebo effect, a meta-analysis.
Rheumatology (Oxford)
; 61(2): 531-541, 2022 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34382085
9.
IL-25 participates in keratinocyte-driven dermal matrix turnover and is reduced in systemic sclerosis epidermis.
Rheumatology (Oxford)
; 61(11): 4558-4569, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35171244
10.
Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: a study from the EUSTAR cohort.
Rheumatology (Oxford)
; 61(3): 1141-1147, 2022 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34146098
11.
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment.
Rheumatology (Oxford)
; 61(10): 4035-4046, 2022 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35238334
12.
Correlation of nailfold capillaroscopy findings with history of digital ulcer on same finger: Results of SCLEROCAP study.
Microvasc Res
; 142: 104365, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35367233
13.
MRI and spondyloarthropathy: diagnostic performance compared to long-term clinical follow-up with evaluation of gadolinium chelates injection.
Eur Radiol
; 32(3): 1409-1418, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34553254
14.
JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study.
Eur J Clin Pharmacol
; 78(12): 1981-1990, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36284012
15.
Re-thinking our understanding of immunity: Robustness in the tissue reconstruction system.
Semin Immunol
; 36: 45-55, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29550156
16.
Urinary incontinence in systemic sclerosis: a prospective multicentre cohort study.
Rheumatol Int
; 42(12): 2141-2150, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35945297
17.
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.
JAMA
; 328(11): 1053-1062, 2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36125471
18.
Methotrexate and rheumatoid arthritis associated interstitial lung disease.
Eur Respir J
; 57(2)2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32646919
19.
TGFß promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis.
Ann Rheum Dis
; 80(12): 1594-1603, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34285051
20.
The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort.
Rheumatology (Oxford)
; 60(11): 5028-5041, 2021 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580257